click below
click below
Normal Size Small Size show me how
Week 4 - Chapter 5
Nonopioid Analgesics
| Term | Definition |
|---|---|
| Perception | Physical components of pain |
| Reaction | Psychologic components of pain |
| Antipyretic | Ability to reduce a fever: affect the hypothalamus (controls the body temperature) |
| Anti-inflammatory | Ability to reduce inflammation |
| Uricosuric | Ability to increase the excretion of uric acid in the urine |
| Antiplatelet | Ability to inhibit the aggregation (clumping) of platelets in the blood |
| Analgesic | Ability to reduce or relieve pain |
| PGE | Prostaglandins, which are lipids produced by cells during inflammation and can sensitive the pain receptors |
| TNF-⍺ | Cytokine that is released by cells during the inflammatory response in periodontal disease |
| Salicylates Drugs | Aspirin (Bayer, Bufferin) |
| NSAIDS | ibuprofen (Advil) naproxen (Aleve) diclofenac (Cataflam) nabumetone (Relafen) meloxicam (Mobic) celecoxib (Celebrex) |
| Nonsalicylates/Nonnarcotics | acetaminophen (Tylenol) |
| Antigout Drugs | colchicine (Colcrys, Mitigare) allopurinol (Zyloprim) |
| Arthritis Drugs | DMARD/Antimetabolite: methotrexate (Otrexup) *DMARD/TNF-a Inhibitor: adalimumab (Humira) *DMARD/TNF-a Inhibitor: etanercept (Enbrel) NSAIDs: celecoxib (Celebrex) *DMARD/Antimalaria: hydroxychloroquine (Plaquenil) |